Immunomodulatory effect of hypertonic saline in hemorrhagic shock

Area of Science:

• Trauma and Emergency Medicine
• Immunology
• Critical Care

Background:

• Multiple organ dysfunction syndrome (MODS) and nosocomial infections are leading causes of mortality in hemorrhagic shock.
• Immune system dysregulation is central to MODS, suggesting immunomodulatory fluids could aid resuscitation.
• Hypertonic saline (HS) is a common resuscitation fluid with known hemodynamic and immunomodulatory effects.

Purpose of the Study:

• To review clinical evidence on the efficacy of hypertonic saline (HS) resuscitation in trauma-hemorrhage patients.
• To evaluate HS's impact on organ failure, mortality, and nosocomial infections.
• To explore discrepancies between animal model findings and human clinical outcomes.

Main Methods:

• Review of clinical studies investigating hypertonic saline (HS) resuscitation in trauma-hemorrhage.
• Analysis of data on survival, organ failure, and infection rates.
• Post hoc analysis of specific patient subgroups (e.g., severely injured, massive transfusion, surgery, TBI).

Main Results:

• Pre-hospital and emergency department HS administration did not improve survival, organ failure, or reduce nosocomial infections in human studies.
• Post hoc analysis indicated potential benefits of HS for severely injured patients, those receiving massive transfusions, undergoing surgery, or with traumatic brain injury.
• Animal models showed promising results, but clinical outcomes were less consistent.

Conclusions:

• While HS exhibits immunomodulatory properties beneficial in animal models, its clinical efficacy in improving overall survival and reducing infections in trauma-hemorrhage shock is not consistently demonstrated.
• Further research and subgroup analysis are needed to identify specific patient populations who may benefit from HS resuscitation.
• Discrepancies between animal and clinical data highlight the complexity of hemorrhagic shock and resuscitation in humans.